David James Lennon's Insider Trades & SAST Disclosures
David James Lennon's most recent trade in Whitehawk Therapeutics Inc. was a trade of 775,828 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David James Lennon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 775,828 | 775,828 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 775,828 | 775,828 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 39,119 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 48,750 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 5,690 | 33,429 | - | 2.4 | 13,372 | Common Stock |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 0 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 32,558 | - | 0 | Common Stock | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 02 Oct 2024 | 9,689 | 22,869 | - | 1.9 | 18,797 | Common Stock |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 65,000 | 65,000 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc. | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,768 | 30,768 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges